The clinical course of alcoholic cirrhosis: Effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia - A historical cohort study

被引:17
作者
Peter Jepsen
Peter Ott
Per Kragh Andersen
Hendrik Vilstrup
机构
[1] Department of Medicine v (Hepatology and Gastroenterology), Aarhus University Hospital, Aarhus
[2] Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus
[3] Department of Biostatistics, Institute of Public Health, University of Copenhagen, Copenhagen
关键词
Alcoholic liver disease; Ascites; Hepatic encephalopathy; Prognosis; Variceal bleeding;
D O I
10.1186/1756-0500-5-509
中图分类号
学科分类号
摘要
Background: The cirrhosis complications hepatic encephalopathy, ascites, and variceal bleeding increase mortality but develop in random sequence. Therefore prognoses based on the presence or absence of these clinical complications are inherently inaccurate, and other determinants of the clinical course should be identified. Here we present our study of patho-etiological factors that may be causally involved in the development of specific complications to alcoholic cirrhosis; it was based on a model of cirrhosis pathophysiology encompassing hepatic metabolic capacity, continued alcohol consumption, and circulatory dysfunction. Methods. We followed a Danish community-based cohort of 466 patients with alcoholic cirrhosis. Stratified Cox regression was used to examine the effects of GEC (a measure of hepatic metabolic capacity), alcohol consumption, and plasma sodium concentration (a measure of circulatory dysfunction) on the hazard rates of first-time hepatic encephalopathy, first-time ascites, first-time variceal bleeding, and mortality. We adjusted for confounding by comorbidity, gender, and age. Data on risk factors and confounders were updated during follow-up. Results: A low GEC increased the risk of first-time hepatic encephalopathy (hazard ratio [HR] 1.21 per 0.1 mmol/min GEC loss, 95% CI 1.11-1.31), but was unassociated with other adverse events. Alcohol consumption increased the risk of first-time ascites (HR 3.18, 95% CI 1.19-8.47), first-time variceal bleeding (HR 2.78, 95% CI 1.59-4.87), and mortality (HR 2.45, 95% CI 1.63-3.66), but not the risk of first-time hepatic encephalopathy. Hyponatremia increased the risk of all adverse events. Conclusions: Reduced hepatic metabolic capacity, alcohol consumption, and hyponatremia were causally involved in the development of specific complications to alcoholic cirrhosis. © 2012 Jepsen et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 20 条
[1]  
Jepsen P., Ott P., Andersen P.K., Sorensen H.T., Vilstrup H., The clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study, Hepatology, 51, pp. 1675-1682, (2010)
[2]  
Gerlach J.C., Brayfield C., Puhl G., Borneman R., Muller C., Schmelzer E., Zeilinger K., Lidocaine/monoethylglycinexylidide test, galactose elimination test, and sorbitol elimination test for metabolic assessment of liver cell bioreactors, Artif Organs, 34, pp. 462-472, (2010)
[3]  
Jepsen P., Vilstrup H., Ott P., Keiding S., Andersen P.K., Tygstrup N., The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: A cohort study, BMC Gastroenterol, 9, (2009)
[4]  
Saunders J.B., Walters J.R.F., Davies P., Paton A., A 20-year prospective study of cirrhosis, British Medical Journal, 282, 6260, pp. 263-266, (1981)
[5]  
Kim W.R., Biggins S.W., Kremers W.K., Wiesner R.H., Kamath P.S., Benson J.T., Edwards E., Therneau T.M., Hyponatremia and mortality among patients on the liver-transplant waiting list, N Engl J Med, 359, pp. 1018-1026, (2008)
[6]  
Jepsen P., Vilstrup H., Andersen P.K., Lash T.L., Sorensen H.T., Comorbidity and survival of Danish cirrhosis patients: A nationwide population-based cohort study, Hepatology, 48, 1, pp. 214-220, (2008)
[7]  
D'Amico G., Garcia-Tsao G., Pagliaro L., Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies, Journal of Hepatology, 44, 1, pp. 217-231, (2006)
[8]  
Frank L., When an entire country is a cohort, Science, 287, 5462, pp. 2398-2399, (2000)
[9]  
Christensen E., Altman D.G., Neuberger J., De Stavola B.L., Tygstrup N., Williams R., Benhamou J.-P., Crowe J., Doniach D., De Groote J., Iversen K., Juhl E., Mistills S., Popper H., Portmann B., Ranek L., Ring-Larsen H., Rodes J., Schaffner F., Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model, Gastroenterology, 105, 6, pp. 1865-1876, (1993)
[10]  
Yun B.C., Kim W.R., Hyponatremia in hepatic encephalopathy: An accomplice or innocent bystander?, Am J Gastroenterol, 104, pp. 1390-1391, (2009)